Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives
Antitrypanosomal Activity of 1,2-Dihydroquinolin-6-ols and Their Ester Derivatives
复制标题
DOI:
10.1021/jm900723w
复制
发表时间:
2010-02-11
影响因子:
7.3
通讯作者:
Werbovetz, Karl A.
中科院分区:
文献类型:
--
作者:
Fotie, Jean;Kaiser, Marcel;Werbovetz, Karl A.
The current chemotherapy for second stage human African trypanosomiasis is unsatisfactory. A synthetic optimization study based on the lead antitrypanosomal compound 1,2-dihydro-2,2,4-trimethylquinolin-6-yl 3,5-dimethoxybenzoate (TDR20364, 1a) was undertaken in an attempt to discover new trypanocides with potent in vivo activity. While 6-ether derivatives were less active than the lead compound, several N1-substituted derivatives displayed nanomolar IC50 values against T. b. rhodesiense STIB900 in vitro, with selectivity indexes up to > 18000. 1-Benzyl-1, 2-dlhydro-2,2,4-trimethylquinolin-6-yl acetate (10a) displayed an IC50 value of 0.014 mu M against these parasites and a selectivity index or 1700. Intraperitoneal administration of 10a at 50 (mg/kg)/day for 4 days caused a promising prolongation of lifespan in T. b. brucei STIB795-infected mice (> 14 days vs 7.75 days for untreated controls). Reactive oxygen species were produced when T. b. brucei were exposed to 10a in vitro, implicating oxidative stress in the trypanocidal mode of action of these 1,2-dihydroquinoline derivatives.